2014 annual financial data

Relmada Therapeutics 2014 Net margin

Relmada Therapeutics 2014 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -17,099,280 USD and net income was -20,803,596 USD.
Operating cash flow was -16,226,728 USD.

Get free Relmada Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-17,099,280 USD
Net income
-20,803,596 USD
Operating cash flow
-16,226,728 USD